Pharmacokinetic Changes in CKD

Patients with CKD have alterations in all of the pharmacokinetic parameters; absorption, distribution, metabolism and elimination (ADME). These ADME


© 2007 S. Karger AG, Basel 0253-5068/07/0251-0133$23.50/0

Bruce A. Mueller, Pharm D, FCCP

Department of Clinical Services, College of Pharmacy

University of Michigan, 428 Church Street

Ann Arbor, MI 48109-1065 (USA)

E-Mail [email protected]

changes have been well detailed [5] and must be considered by the clinician before instituting drug therapy. ADME changes in the CKD patient can result in changes in the disposition of a drug and its pharmacologic effect. In this article we address many issues surrounding pharmacotherapy and monitoring in the CKD patient and propose practical approaches to selected drug-dosing dilemmas.

0 0

Post a comment